Rankings
▼
Calendar
AMRX Q3 2017 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
Q3 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$255M
Gross Profit
$135M
53.0% margin
Operating Income
$79M
30.9% margin
Net Income
$27M
10.5% margin
EPS (Diluted)
$0.23
QoQ Revenue Growth
-2.0%
Cash Flow
Operating Cash Flow
$74M
Free Cash Flow
$38M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$1.7B
Stockholders' Equity
-$437M
Cash & Equivalents
$19M
← FY 2017
All Quarters
Q4 2017 →
